This inventor holds 9 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignees: Agency of Industrial Science and Technology, National Institute of Advanced Industrial Science and Technology. Active years: 1999-2014.
Location History:
- Tokyo, JP (1999 - 2007)
- Tsukuba, JP (2010 - 2011)
- Ibaraki, JP (2009 - 2014)
Company Filing History:
5 out of 1,430 
4 out of 1,762 
Years Active: 1999-2014
Title: Toru Imamura: Innovator in Pharmaceutical Composition and Receptor Activity
Introduction
Toru Imamura is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceutical compositions and receptor activity, holding a total of 9 patents. His work focuses on innovative methods for screening substances that activate receptors associated with metabolic functions.
Latest Patents
One of Imamura's latest patents is a method for screening a test substance for activating a receptor associated with FGF 21 activity. This invention utilizes betaKlotho or substances that modulate betaKlotho activity as agents for controlling FGF21-mediated activity. The pharmaceutical composition developed from this invention is particularly aimed at addressing metabolic syndrome and controlling blood glucose levels. Additionally, he has developed a screening system that identifies substances that enhance or suppress betaKlotho activity, utilizing a cell system expressing FGF receptors and/or betaKlotho.
Another significant patent involves an isolated mutant protein of fibroblast growth factor 18. This mutant protein has altered receptor specificity and is produced by deleting amino acid residues from the N-terminus of the naturally secreted fibroblast growth factor 18. This protein can be utilized in pharmaceutical compositions aimed at regulating hair regeneration or growth, as well as bone or cartilage formation.
Career Highlights
Throughout his career, Toru Imamura has worked with esteemed organizations such as the Agency of Industrial Science and Technology and the National Institute of Advanced Industrial Science and Technology. His contributions to these institutions have been pivotal in advancing research in the field of biotechnology and pharmaceuticals.
Collaborations
Imamura has collaborated with notable colleagues, including Masashi Suzuki and Masahiro Asada. These partnerships have fostered innovation and have led to the development of groundbreaking technologies in receptor activity and pharmaceutical applications.
Conclusion
Toru Imamura's work exemplifies the intersection of innovation and practical application in the pharmaceutical industry. His patents and research continue to influence the development of treatments for metabolic disorders and regenerative medicine.